Leaders call for ICE to release Chicago area man whose daughter has cancer
Local leaders are calling for the release of a Niles man who was detained by federal immigration agents as his 16-year-old daughter undergoes treatment for a rare form of cancer.
Illinois father detained by ICE amid teen daughter's cancer treatment, lawmakers call for his release
Illinois lawmakers are demanding ICE release a father detained over the weekend as his teen daughter fights Stage 4 cancer.
Early Detection Saves Lives: Mercy Saye’s Breast Cancer Journey
Mercy Saye, a 38-year-old Rogers Park resident credits early detection and swift care at Northwestern Medicine for saving her life after a breast cancer diagnosis at age 37. Mercy’s story began in the shower, when she found a lump in her right breast in November 2023. She hadn’t done a self-check in a while and followed her instinct to examine herself. Her primary care doctor referred her to Northwestern Medicine Evanston Imaging Center, where Sonya Bhole, MD, a radiologist, quickly identified the need for a biopsy following a diagnostic mammogram. She is now cancer-free and passionate about raising awareness, especially among Black women, about the importance of early detection. ChicagoNOW is a fast-paced, conversational show that spotlights what’s trending in and around Chicago.
Dog given less than 6 months to live cured of cancer after clinical trial
Lola has now been cancer free for two years.
Montell Jordan says his cancer has returned after having prostate removed
The R&B singer, who was diagnosed with prostate cancer last year, shared his story in a recent interview.
Orland Park man cycling 225 miles to raise money for great cause
Mike Roach is participating in the Bristol Myers Squibb’s Coast 2 Coast 4 Cancer ride to raise money for cancer research in support of the V Foundation. This marks his fifth time participating in Coast 2 Coast 4 Cancer but the first time he’s riding through Illinois – his home state.
New vaccine designed to help fight colorectal, pancreatic cancer shows promising results: Study
The vaccine, which has completed its phase 1 trial, is called ELI-002 2P.
